Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that six clinical abstracts demonstrating the broad use of its NeXT Personal® test will be ...
Cathie Wood’s Bold Investment; Personalis (NASDAQ:PSNL) reported first-quarter 2026 revenue of $15.5 million as management said the company is p ...
Koya Medical ("Koya"), an emerging medtech innovator advancing patient-centered solutions in vascular health, has announced its participation in the following investor conferences from June 2 to June ...
In a report released today, Michael Matson from Needham reiterated a Buy rating on Personalis, with a price target of $12.00. According to TipRanks, Matson is a 2-star analyst with an average return ...
LimmaTech Biologics AG, a Swiss clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced entry into a definitive agreement to be acquired by ...
A recent Gandhinagar court ruling has declared iCloud data a 'heritable estate asset', reigniting debate over who controls ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Abbott (NYSE: ABT) will present 11 abstracts featuring new evidence across the cancer care continuum at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 – June 2, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results